Ym Biosciences

Developed JAK inhibitor for myelofibrosis

placeToronto, Ontario, Canada calendar_todayFounded 1994 language ymbiosciences.com

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Private equity150%
Coming soon